e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Treatment and risk factors in lower respiratory tract infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An audit on antibiotic prescribing knowledge in LRTI
R. Sarkar, C. Bhatnagar, G. Jones, O. Ejere, E. Brohan, A. de Ramón Casado (Warrington, United Kingdom)
Source:
Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Session:
Treatment and risk factors in lower respiratory tract infections
Session type:
E-Communication Session
Number:
5195
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Sarkar, C. Bhatnagar, G. Jones, O. Ejere, E. Brohan, A. de Ramón Casado (Warrington, United Kingdom). An audit on antibiotic prescribing knowledge in LRTI. Eur Respir J 2010; 36: Suppl. 54, 5195
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice.
Source: International Congress 2017 – COPD management
Year: 2017
Antibiotic prescribing practises of hospital doctors for COPD exacerbations
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Can CAP guideline adherence improve patient outcome in internal medicine departments?
Source: Eur Respir J 2008; 32: 902-910
Year: 2008
Barriers to adherence to key indicators of antibiotic use for community-acquired pneumonia: a qualitative study
Source: Eur Respir J 2005; 26: Suppl. 49, 258s
Year: 2005
The assessment of physicians' knowledge of community-acquired pneumonia basics: KNOCAP study
Source: International Congress 2019 – Medical education
Year: 2019
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Pattern of antibiotic resistance in hospital acquired pneumonia in a country where antibiotics are available over the counter without doctors prescription
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study
Source: Eur Respir J 2004; 24: Suppl. 48, 187s
Year: 2004
A clinical and aetiological evaluation of community acquired pneumonia-are we following guidelines in prescribing antibiotics?
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
ERS guideline compliant antibiotics among hospitalized patients with Community-acquired pneumonia on the ward service
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
Assessment of antibiotic prescribing practises for hospitalised patients with suspected sepsis using a score of "likelihood of infection"
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Audit of the prescription of antibiotic and oxygen therapy and chest Xray requests in community aquired pneumonia in the medical assessment unit
Source: Eur Respir J 2004; 24: Suppl. 48, 229s
Year: 2004
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011
Rational use and stewardship of antibiotics in pediatric respiratory disease
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives
Source: Eur Respir J 2004; 24: Suppl. 48, 185s
Year: 2004
Improving antibiotic utilisation for nosocomial pneumonia
Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Year: 2019
Optimising decision for antibiotic treatment in non-hospitalised CAP patient
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept